DREAM Antikörper (N-Term)
-
- Target Alle DREAM (KCNIP3) Antikörper anzeigen
- DREAM (KCNIP3) (Kv Channel Interacting Protein 3, Calsenilin (KCNIP3))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DREAM Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Rabbit polyclonal antibody raised against synthetic peptide of KCNIP3.
- Kreuzreaktivität
- Human, Maus
- Immunogen
- A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human KCNIP3.
- Top Product
- Discover our top product KCNIP3 Primärantikörper
-
-
- Applikationshinweise
-
Immunofluorescence (1:10-50)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:50-100)
Western Blot (1:1000)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In PBS (0.09 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
Reduced expression of calsenilin/DREAM/KChIP3 in the brains of kainic acid-induced seizure and epilepsy patients." in: Neuroscience letters, Vol. 340, Issue 1, pp. 33-6, (2003) (PubMed).
: "Phosphorylation of calsenilin at Ser63 regulates its cleavage by caspase-3." in: Molecular and cellular neurosciences, Vol. 23, Issue 3, pp. 495-506, (2003) (PubMed).
: "PKA modulation of Kv4.2-encoded A-type potassium channels requires formation of a supramolecular complex." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 22, Issue 23, pp. 10123-33, (2002) (PubMed).
: "
-
Reduced expression of calsenilin/DREAM/KChIP3 in the brains of kainic acid-induced seizure and epilepsy patients." in: Neuroscience letters, Vol. 340, Issue 1, pp. 33-6, (2003) (PubMed).
-
- Target
- DREAM (KCNIP3) (Kv Channel Interacting Protein 3, Calsenilin (KCNIP3))
- Andere Bezeichnung
- Calsenilin (KCNIP3 Produkte)
- Synonyme
- CSEN antikoerper, DREAM antikoerper, KCHIP3 antikoerper, 4933407H12Rik antikoerper, AI413860 antikoerper, Csen antikoerper, KChIP3 antikoerper, R74849 antikoerper, Dream antikoerper, rKChIP3 antikoerper, csen antikoerper, im:7145308 antikoerper, kcnip3 antikoerper, zgc:73306 antikoerper, KCNIP3 antikoerper, potassium voltage-gated channel interacting protein 3 antikoerper, Kv channel-interacting protein 4 antikoerper, calsenilin antikoerper, Kv channel interacting protein 3, calsenilin antikoerper, Kv channel interacting protein 3b, calsenilin antikoerper, KCNIP3 antikoerper, LOC5568664 antikoerper, CpipJ_CPIJ002549 antikoerper, Tsp_05009 antikoerper, Kcnip3 antikoerper, kcnip3b antikoerper, kcnip3 antikoerper
- Gen-ID
- 30818
-